1. Home
  2. AXTI vs ELEV Comparison

AXTI vs ELEV Comparison

Compare AXTI & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • ELEV
  • Stock Information
  • Founded
  • AXTI 1986
  • ELEV 2019
  • Country
  • AXTI United States
  • ELEV United States
  • Employees
  • AXTI N/A
  • ELEV N/A
  • Industry
  • AXTI Semiconductors
  • ELEV Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • ELEV Health Care
  • Exchange
  • AXTI Nasdaq
  • ELEV Nasdaq
  • Market Cap
  • AXTI 146.1M
  • ELEV 155.7M
  • IPO Year
  • AXTI 1998
  • ELEV 2021
  • Fundamental
  • Price
  • AXTI $2.32
  • ELEV $0.63
  • Analyst Decision
  • AXTI Strong Buy
  • ELEV Strong Buy
  • Analyst Count
  • AXTI 4
  • ELEV 5
  • Target Price
  • AXTI $5.38
  • ELEV $7.80
  • AVG Volume (30 Days)
  • AXTI 217.0K
  • ELEV 846.8K
  • Earning Date
  • AXTI 10-31-2024
  • ELEV 10-31-2024
  • Dividend Yield
  • AXTI N/A
  • ELEV N/A
  • EPS Growth
  • AXTI N/A
  • ELEV N/A
  • EPS
  • AXTI N/A
  • ELEV N/A
  • Revenue
  • AXTI $88,406,000.00
  • ELEV N/A
  • Revenue This Year
  • AXTI $40.18
  • ELEV N/A
  • Revenue Next Year
  • AXTI $21.52
  • ELEV N/A
  • P/E Ratio
  • AXTI N/A
  • ELEV N/A
  • Revenue Growth
  • AXTI N/A
  • ELEV N/A
  • 52 Week Low
  • AXTI $1.89
  • ELEV $0.36
  • 52 Week High
  • AXTI $5.64
  • ELEV $5.83
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 34.75
  • ELEV 21.64
  • Support Level
  • AXTI $2.58
  • ELEV $0.70
  • Resistance Level
  • AXTI $2.77
  • ELEV $0.80
  • Average True Range (ATR)
  • AXTI 0.14
  • ELEV 0.07
  • MACD
  • AXTI -0.01
  • ELEV 0.06
  • Stochastic Oscillator
  • AXTI 8.57
  • ELEV 5.80

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Share on Social Networks: